Navigation Links
Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results
Date:2/28/2011

hs Ended December 31, 2009 (unaudited) Actual Reported (GAAP) AdjustmentsAdjustedTotal Revenues$  391,406

$  —$  391,406Costs and expenses: Cost of revenues

99,673

(19,339)

(1)

80,334 Selling, general and administrative

145,003

—145,003 Research and development

48,705

(15,979)

(2)

32,726 Impairment of intangibles

69,000

(69,000)

(3)

— Acquisition-related items

(134,303)

134,303

(4)

—Operating income163,328

(29,985)133,343 Interest expense, net

9,505

(4,020)

(5)

5,485 Other (income) expense, net

(1,725)

1,555

(6)

(170)Income before income taxes155,548

(27,520)128,028 Income taxes

7,700

25,181

(7)

32,881Net income$  147,848

$  (52,701)$  95,147Diluted earnings per share

$  1.25$  0.81Diluted weighted average shares

117,859117,859Notes to reconciliation of our GAAP statements of operations to our adjusted statements of operations:(1)

To exclude amortization of commercial intangible assets related to marketed products of $19,217 and the impact of an Indevus inventory step-up recorded as part of acquisition accounting of $122.(2)

To exclude upfront and milestone payments to partners.(3)

To exclude the impairment of AVEED and PRO2000 for $65,000 and $4,000, respectively.(4)

To exclude Indevus transaction and separation cost reversals of ($2,973) as well as the impact, under purchase accounting, of a gain recorded to reflect the change in the company's current estimate of fair value, in accordance with GAAP, of the contingent consideration associated with the Indevus acquisition of ($131,330).(5)

To exclude additional interest expense as a result of adopting ASC 470-20 of $4,114 and to ex
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology
2. Savient Pharmaceuticals Announces U.S. Launch of KRYSTEXXA™; Reports Fourth Quarter and Year-End 2010 Financial Results
3. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
4. Cumberland Pharmaceuticals Appoints Tan Cheow Choon as Director of International Business
5. Anadys Pharmaceuticals to Report Fourth Quarter and Year-end 2010 Financial Results
6. UCLA and Sound Pharmaceuticals Identify a Key Hearing Regeneration Protein in the Human Inner Ear
7. JHP Pharmaceuticals Enters Another Multi-Year Contract Manufacturing Agreement
8. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Fourth Quarter and Full Year Financial Results
9. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
10. Jazz Pharmaceuticals to Present at the Citi 2011 Global Health Care Conference in New York on March 1
11. Tarix Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Study of TXA127 Following Autologous Peripheral Blood Stem Cell Transplant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... WASHINGTON and NEW YORK ... 2014 As the leading distributor of market ... a new research report by IQ4I Research and Consultancy ... To learn more about IQ4I Research visit: ... Active Pharmaceutical Ingredients Global Market – Forecast ...
(Date:11/26/2014)...  At the American Dental Association,s Annual Meeting in ... Kerr Group was honored to be part of the ... to see and test the Best of Class winners ... on the latest developments in dental technology. This year, ... CariVu Caries Detection Device and Kerr Demi ™  ...
(Date:11/26/2014)... , Nov. 25, 2014 Reinforcing its ... Philips (NYSE: PHG AEX: PHIA) ... Drug Administration (FDA) for its IQon Spectral CT ... This first-of-its kind technology adds a new dimension to ... the ability to characterize structures based on their material ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3
... ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today ... will present at the 10th Annual BIOInvestor Forum Conference on ... the Sea Cliff Salon at the Palace Hotel in San ... audio webcast and slide presentation on the ADVENTRX Pharmaceuticals web ...
... YORK, Oct. 19, 2011 Reportlinker.com announces that ... its catalogue: Flow Cytometry: Products, ... http://www.reportlinker.com/p0568366/Flow-Cytometry-Products-Technologies-and-Global-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic REPORT HIGHLIGHTS ... * An overview of the flow cytometry ...
Cached Medicine Technology:Flow Cytometry: Products, Technologies and Global Markets 2Flow Cytometry: Products, Technologies and Global Markets 3Flow Cytometry: Products, Technologies and Global Markets 4Flow Cytometry: Products, Technologies and Global Markets 5Flow Cytometry: Products, Technologies and Global Markets 6Flow Cytometry: Products, Technologies and Global Markets 7Flow Cytometry: Products, Technologies and Global Markets 8Flow Cytometry: Products, Technologies and Global Markets 9Flow Cytometry: Products, Technologies and Global Markets 10Flow Cytometry: Products, Technologies and Global Markets 11Flow Cytometry: Products, Technologies and Global Markets 12
(Date:11/28/2014)... York, NY (PRWEB) November 28, 2014 ... Salvage ( http://www.rustysautosalvage.com ), one of the nation's leading ... junk and salvage vehicles to be more competitive and ... customer’s lives during this festive time of year. , ... many car owners across the US also deal with ...
(Date:11/28/2014)... Novatus, a leading provider of contract ... provides customers with greater reporting capabilities, more searchable ... we continue to evolve and grow the Novatus ... improved performance in response to requests from our ... the enhancements that we have made to Advanced ...
(Date:11/28/2014)... November 28, 2014 Dr. Andrew Campbell, ... , announced the expansion of Quintessa Aesthetic Center into ... be located at W307 N1497 Golf Road in Suite ... to Dr. Campbell, the new Delafield location will offer ... for patients, including: Botox, filler injectables , micro ...
(Date:11/28/2014)... 28, 2014 Dr. Paul Vitenas, one of the ... Glitter & Glow Holiday Event for those in the area that ... his practice. Glitter & Glow will take place on December 11, ... location in the heart of Houston at 4208 Richmond Ave. ... hope that you will come and celebrate the season with us ...
(Date:11/28/2014)... 2014 Written and narrated by award winning ... releases the “The Happiest Man In the World: Life ... of how and why Project C.U.R.E. came to be. , ... Josie and the Reverend Richard W. Jackson, Dr. Jackson exceeded ... 30, but realized that he wasn’t happy. Prompted by this ...
Breaking Medicine News(10 mins):Health News:Rusty's Auto Salvage Increasing Their Cash Offers to Help Drivers Save Throughout the Busy Holiday Season 2Health News:Novatus Releases v5.1 with New Advanced Reporting Capabilities 2Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2
... Doctor ... Information and Reviews, NEW YORK, Jan. 28 ... relations firms, today announced the addition of,Vitals.com to its client roster. ... free, online doctor evaluation,service., Vitals.com provides consumers with access -- ...
... Dr. Cheryl Healton, President and CEO, WASHINGTON, ... New York State Department of Health for taking ... Administration (FDA) to,allow over-the-counter sales of nicotine replacement ... sold. This petition attempts to move,forward easier access ...
... Purposes Granted to Global Vaccines, FT. ... 28, InkSure Technologies Inc. (OTC Bulletin Board:,INKS), ... solutions,("CMRT") for the detection of counterfeiting, fraud ... of innovative authentication,and item-level identification technologies, today ...
... Disease Claims as Many Lives Each Year as Breast ... For the second,year in a row, pulmonary fibrosis ... Union address. Just a year ago, Caesar Borja, Jr.,attended ... after his,father lost his fight to live as he ...
... YORK, Jan. 28 Nanotech Briefs has announced a ... competition, which,launched on January 7. The Nano 50 recognizes ... potential to advance the,commercialization of nanotechnology., Nominations are ... at,the official awards Web site: http://www.nanotechbriefs.com/nano50 . The ...
... short strands of RNA that can interfere with ... how closely they are associated with cancer. In a ... colleagues have identified two microRNAs (miRNAs) that promote tumors ... provide an early warning of metastatic breast cancer and ...
Cached Medicine News:Health News:MWW Group Selected by First-Ever Online Doctor Evaluation Service Vitals.com 2Health News:American Legacy Foundation Comments on New York State Department of Health Petition to the FDA to Expand Consumer Access to Over the Counter Nicotine Medications 2Health News:InkSure and AuthentiForm Announce Assignment of Patent Portfolio 2Health News:InkSure and AuthentiForm Announce Assignment of Patent Portfolio 3Health News:Pulmonary Fibrosis Patients/9/11 Responders Represented at State of the Union Address for Second Year in a Row 2Health News:Nanotech Briefs Announces Call for Nominations for the Fourth Annual Nano 50(TM) Awards 2Health News:2 microRNAs promote spread of tumor cells 2Health News:2 microRNAs promote spread of tumor cells 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: